Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR1153392Aexternal-prioritypatent/FR2974300B1/en
Priority claimed from FR1153396Aexternal-prioritypatent/FR2974296B1/en
Application filed by Inneov LabfiledCriticalInneov Lab
Publication of AR086106A1publicationCriticalpatent/AR086106A1/en
Uso de una combinación (i) de al menos un carotenoide, por ejemplo, licopeno, (ii) de al menos un fitoestrógeno, con preferencia, un isoflavonoide, y (iii) de vitamina C como un agente activo, para el embellecimiento de la piel, o para la preparación de una composición cosmética adecuada para la administración por vía oral de una dosis diaria comprendida entre 1 y 25 mg de un carotenoide, entre 10 y 300 mg de un fitoestrógeno y entre 10 y 1000 mg de vitamina C.Use of a combination (i) of at least one carotenoid, for example, lycopene, (ii) of at least one phytoestrogen, preferably an isoflavonoid, and (iii) of vitamin C as an active agent, for beautification of the skin, or for the preparation of a cosmetic composition suitable for oral administration of a daily dose between 1 and 25 mg of a carotenoid, between 10 and 300 mg of a phytoestrogen and between 10 and 1000 mg of vitamin C.
ARP1201013222011-04-192012-04-18
USE OF A COMBINATION OF A CAROTENOID, A PHYTOESTROGEN AND VITAMIN C AS AN ACTIVE AGENT, FOR SKIN BEAUTY
AR086106A1
(en)
Arginine salt and one or more conjugated acids; oral care composition comprising said salt; use to reduce or inhibit caries formation, demineralization of teeth; reduce hypersensitivity of teeth, reduce or inhibit gingivites among others.
Topical pharmaceutical or cosmetic composition useful for the treatment of diseases or conditions that present with a deficit of the maturation of the cornea envelope
Cosmetic composition comprising 0.0001 to 10% by weight of guacatonga extract (casearia sylvestris) and 0.00005 to 10% by weight of aroeira extract (schinus terebinthifolius raddi) both with respect to the total weight of the composition; use of the composition in the prevention and / or treatment of signs of skin aging; method to prevent and / or treat the signs of skin aging.
Pharmaceutical composition in the form of an oral suspension comprising as active ingredient a fraction of flavonoid and as an excipient xanthan gum in the amount of 0.30% w / w to 0.60% w / w; use for the treatment of venous insufficiency.